(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MOMALIFE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MOMALIFE

ST13

US500000088374626

Class

5

Filing

88374626

Registration

6045321

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

05/06/2025

Trademark type

Word

Nice classes

5

Filing date

04/06/2019

Registration date

05/05/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/05/2020

Last transaction

05/06/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

01

Owner location

Etobicoke, ON, CA

Examiner

DAWE III, BILL

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

H. A. (pessoa física)

Representatives

Francis John Ciaramella, Esquire Francis John Ciaramella, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutritional pharmaceutical preparationsmedicinal herbal preparations and phyto-drugspharmaceutical preparations for maintaining good cellular healthslowing down the aging processproviding vital energy for growthanti-agingcardiovascular health and the prevention of cancerpromoting cellular growthenhancing the immunity systemhelping to lower low-density lipoprotein (LDL) cholesterol and raise high-density lipoprotein (HDL) cholesterolpromoting healthy blood sugarcontrolling blood sugar for pre-diabetesimproving and maintaining kidney and liver healthimproving sexual desire and enhancing the libidopreventing cardiovascular diseasemaintaining cellular healthlowering lipids in the blood and for the prevention of colonbreast and prostate cancer; and nutraceuticalscosmeceuticalspharmaceutical and dermatological preparationsmedicinal herbal preparations and phyto-drugspharmaceutical preparations as gelsointments and creams for skin healthfor the treatment of skin conditionsdermatitiseczemapsoriasis and for the treatment of acne

Publications

History of USPTO decisions and trademark events.

25 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/05/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/18/2020

PUBO

PUBLISHED FOR OPPOSITION

02/18/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/29/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/13/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

01/13/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/13/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

01/13/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/13/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/13/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/09/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/10/2019

GNRT

NON-FINAL ACTION E-MAILED

07/10/2019

CNRT

NON-FINAL ACTION WRITTEN

07/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/01/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/01/2019

ALIE

ASSIGNED TO LIE

06/28/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/23/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/17/2019

GNRT

NON-FINAL ACTION E-MAILED

06/17/2019

CNRT

NON-FINAL ACTION WRITTEN

06/17/2019

DOCK

ASSIGNED TO EXAMINER

06/17/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/23/2019

Continuous trademark protection

Get notified about every new filing that threatens MOMALIFE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.